UNSPSC 51412500: Vasodilator phenothiazines

Vasodilator drugs made from compounds containing dibenzo-1,4-thiazine.

UNSPSC 51412500 Vasodilator phenothiazines is a Class code that does not match the state and local procurement activity actually tagged to it in current opportunities. The three recent solicitations under this code involve advanced life support medications, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and over-the-counter products — none of which center on vasodilator phenothiazines as a distinct product category. The City of Tampa's sealed-bid solicitation for Advanced Life Support Medications names four specific drug line items (Labetalol HCI, Epinephrine, Adenosine, and Diltiazem) for Tampa Fire Rescue, none phenothiazine-class; the Texas Health and Human Services Commission's RFI seeks vendor capability for direct-to-manufacturer prescription fulfillment without specifying drug classes; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP covers generic pharmaceuticals and OTC products at the manufacturer level across multiple state and local jurisdictions. State and local issuing bodies in these opportunities include municipal fire services, state health agencies, and cooperative purchasing alliances spanning multiple jurisdictions. The code shows material recent activity but little alignment with its nominal scope.

Geographic spread includes Florida (Tampa Fire Rescue), Texas (HHS Commission), and Minnesota (MMCAP, serving Minnesota, Oregon, and other participating states). Representative opportunities include the City of Tampa's sealed-bid solicitation 26P00188 due April 8, 2026, with an estimated contract value of $40,000 and a one-year term plus optional renewals, sheltered to Small Local Business Enterprises with a 5 percent bid discount; the Texas HHS RFI HHS0017013 (posted April 3, 2026, closed April 3, 2026) seeking market intelligence on direct-to-manufacturer prescription models; and the Minnesota MMCAP RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products, with a two-year contract term and pricing weighted 75 percent on competitiveness. Given the mismatch between the code name and the actual procurement activity tagged to it, business development professionals should verify the correct UNSPSC code classification before pursuing opportunities in this category.